ID   OMC-9
AC   CVCL_3355
SY   OMC9; Osaka Medical College-9
DR   CLO; CLO_0050888
DR   BioSample; SAMN03471932
DR   RCB; RCB2832
DR   Wikidata; Q54932038
RX   PubMed=18397474;
CC   Population: Japanese.
CC   Doubling time: 36.6 hours (Note=At 29th passage) (PubMed=18397474).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
ST   Source(s): RCB
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 19,20
DI   NCIt; C8973; Endometrioid stromal sarcoma
DI   ORDO; Orphanet_213711; Endometrial stromal sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   PubMed=18397474; DOI=10.1111/j.1749-0774.2008.00050.x;
RA   Kakuno Y., Yamada T., Mori H., Narabayashi I.;
RT   "Establishment and characterization of a cell line (OMC-9) originating
RT   from a human endometrial stromal sarcoma.";
RL   Hum. Cell 21:46-55(2008).
//